Jonathan Bleeker
Sanford Health(US)Sanford USD Medical Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research, Immunotherapy and Immune Responses
Most-Cited Works
- → Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer(2018)1,796 cited
- → Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline(2014)1,208 cited
- → Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update(2020)989 cited
- → “Malignant” Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies(2012)208 cited
- → Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies(2011)141 cited
- → Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers(2022)58 cited
- → Scleroderma‐like skin changes induced by checkpoint inhibitor therapy(2018)56 cited
- → Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study.(2018)49 cited
- → Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma(2015)46 cited
- → KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer(2017)35 cited